Atlas Brown Inc. Purchases New Holdings in Danimer Scientific, Inc. (NYSE:DNMR)

Atlas Brown Inc. purchased a new stake in Danimer Scientific, Inc. (NYSE:DNMRGet Rating) in the second quarter, Holdings Channel.com reports. The firm purchased 29,700 shares of the company’s stock, valued at approximately $135,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of DNMR. Thomasville National Bank raised its stake in Danimer Scientific by 3.3% during the first quarter. Thomasville National Bank now owns 78,792 shares of the company’s stock valued at $462,000 after buying an additional 2,500 shares in the last quarter. Capital Investment Advisors LLC raised its stake in Danimer Scientific by 0.4% during the second quarter. Capital Investment Advisors LLC now owns 830,998 shares of the company’s stock valued at $3,789,000 after buying an additional 3,000 shares in the last quarter. Geneos Wealth Management Inc. raised its stake in Danimer Scientific by 30.2% during the first quarter. Geneos Wealth Management Inc. now owns 15,605 shares of the company’s stock valued at $91,000 after buying an additional 3,615 shares in the last quarter. SouthState Corp raised its stake in Danimer Scientific by 280.0% during the first quarter. SouthState Corp now owns 5,130 shares of the company’s stock valued at $30,000 after buying an additional 3,780 shares in the last quarter. Finally, Teacher Retirement System of Texas raised its position in shares of Danimer Scientific by 34.4% during the 4th quarter. Teacher Retirement System of Texas now owns 15,283 shares of the company’s stock worth $130,000 after purchasing an additional 3,908 shares during the period. Hedge funds and other institutional investors own 44.98% of the company’s stock.

Danimer Scientific Stock Performance

DNMR stock traded down $0.19 on Friday, reaching $3.07. The company’s stock had a trading volume of 57,290 shares, compared to its average volume of 1,064,690. Danimer Scientific, Inc. has a 52 week low of $3.09 and a 52 week high of $20.40. The firm has a fifty day moving average of $4.51 and a two-hundred day moving average of $4.64. The company has a debt-to-equity ratio of 0.56, a quick ratio of 5.53 and a current ratio of 6.60.

Danimer Scientific (NYSE:DNMRGet Rating) last issued its quarterly earnings data on Tuesday, August 9th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.04). Danimer Scientific had a negative return on equity of 19.28% and a negative net margin of 104.97%. The business had revenue of $12.70 million during the quarter. Analysts anticipate that Danimer Scientific, Inc. will post -0.82 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Cowen dropped their price target on Danimer Scientific to $6.00 in a research report on Monday, August 15th.

Insider Buying and Selling

In other Danimer Scientific news, CMO Scott Tuten sold 10,000 shares of the stock in a transaction on Wednesday, August 17th. The stock was sold at an average price of $5.06, for a total transaction of $50,600.00. Following the completion of the transaction, the chief marketing officer now directly owns 464,136 shares of the company’s stock, valued at approximately $2,348,528.16. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Danimer Scientific news, Director Stuart W. Pratt sold 75,327 shares of the stock in a transaction on Thursday, August 18th. The stock was sold at an average price of $5.25, for a total transaction of $395,466.75. Following the completion of the transaction, the director now directly owns 1,519,238 shares of the company’s stock, valued at approximately $7,975,999.50. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CMO Scott Tuten sold 10,000 shares of the stock in a transaction on Wednesday, August 17th. The shares were sold at an average price of $5.06, for a total value of $50,600.00. Following the transaction, the chief marketing officer now directly owns 464,136 shares of the company’s stock, valued at $2,348,528.16. The disclosure for this sale can be found here. Insiders sold 105,327 shares of company stock valued at $532,667 in the last three months. 14.60% of the stock is currently owned by corporate insiders.

Danimer Scientific Profile

(Get Rating)

Danimer Scientific, Inc, a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.

Further Reading

Want to see what other hedge funds are holding DNMR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danimer Scientific, Inc. (NYSE:DNMRGet Rating).

Institutional Ownership by Quarter for Danimer Scientific (NYSE:DNMR)

Receive News & Ratings for Danimer Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danimer Scientific and related companies with MarketBeat.com's FREE daily email newsletter.